|
Post by awesomo on Aug 13, 2019 10:08:20 GMT -5
Institutional investors won’t want any part of a company that just did a reverse split to artificially increase share price beyond some cutoff ownership price. Another reverse split will wipe out existing shareholders, might as well just restructure through bankruptcy at that point.
|
|
|
Post by pat on Aug 13, 2019 10:10:32 GMT -5
I’ve been in this stock for what, 10 years now I think. I’ve accelerated purchases massively the past year.
Did I lose out on equity market gains? Yes.
Do I know when this thing will finally turn? No.
Do I care? No
Bottom line - I will calculate an annualized equivalent return (whether gain or loss) on my investment when I finally exit it. I don’t plan on doing so for many years.
I am increasingly confident that my annualized return will far exceed what it would have been had I left it in a SPYDer.
They (shorts) are in the enviable position of carrying a massive short bet with an annualized financing cost (5%+?) and very little additional upside, with significant downside.
I am only human and exasperated, as all we longs are.
But in the end it won’t change the ultimate outcome.
|
|
|
Post by sportsrancho on Aug 13, 2019 10:20:26 GMT -5
What happens if we go below 1$? Are you thinking RS? Sounds like something is in the works again.. Is management thinking of doing an RS so we can attract institutional investors? Gawd I hope not.. I'm not going through that..I sold the last time, and I will again.. No I’m thinking it does not go below a dollar, but that if it does something is wrong ..and whatever that is I’m not aware of it. With the runway it should keep climbing. But the stock will always tell you more than management will. A RS would keep investors away like awesome says. I truly believe that’s completely off the table ...but I will let the stock show me.
|
|
Deleted
Deleted Member
Posts: 0
|
Post by Deleted on Aug 13, 2019 11:28:11 GMT -5
What happens if we go below 1$? Are you thinking RS? Sounds like something is in the works again.. Is management thinking of doing an RS so we can attract institutional investors? Gawd I hope not.. I'm not going through that..I sold the last time, and I will again.. No I’m thinking it does not go below a dollar, but that if it does something is wrong ..and whatever that is I’m not aware of it. With the runway it should keep climbing. But the stock will always tell you more than management will. A RS would keep investors away like awesome says. I truly believe that’s completely off the table ...but I will let the stock show me. There's too much pending good news for MNKD right now. Whom ever controls the stock price (Not retailers) is going to wait until the very last minute before they start raising the price. You have Brazil Oct. PR, UTHR milestone payment, UTHR new molecule, Cohort 3 official PR and possible EPI Partner PR.....All can happen in the 2H19.
|
|
|
Post by mytakeonit on Aug 13, 2019 13:09:49 GMT -5
sports ... I thought I was awesome? Anyway, don't forget the rubber band is on $1.10 for now. And September is just a few weeks away.
But, that's mytakeonit
|
|
|
Post by cretin11 on Aug 13, 2019 16:01:35 GMT -5
And even better news, October is just a few weeks after September!
Curious how folks feel so confident the share price won't go below $1 again. That's only a 10% dip, seems as likely as not to occur, just based on the history of this thing. Nothing has changed that much for the better in the last several weeks or months. Debt restructure was positive but not a game changer. MC and other insiders aren't loading up at these levels as far as we know. I would love y'all to be right about this, it's way overdue but we've been singing that same tired song for years now.
|
|
|
Post by prcgorman2 on Aug 13, 2019 17:27:20 GMT -5
Good question. I wish I had a good answer. I don't know what to think about the phrase "support at this level" but I have to say there does seem to be something built into buying and selling algorithms and human behavior both that triggers around round dollar amounts. It's not clear to me why a round dollar amount should matter, but it does seem to, so I suspect there is "support at $1". The $1.01 trade can still happen. I bought some shares last year at $1. But those sales revenue graphs that Earl Grey makes, and the QoQ and YoY graphs that Stephen Binder makes tell a story with facts that Mannkind is executing in a positive way over an extended period of time. We talk about what influences investors, those graphs and facts are unlikely to influence sell orders as much as buy orders (is my opinion).
|
|
|
Post by buyitonsale on Aug 13, 2019 17:42:25 GMT -5
UT decision in Q3, within 6 weeks, if they option another drug, share price will not spend much time under 1... or under 2 ...
I believe they will.
|
|
|
Post by ktim on Aug 14, 2019 12:08:47 GMT -5
No I’m thinking it does not go below a dollar, but that if it does something is wrong ..and whatever that is I’m not aware of it. With the runway it should keep climbing. But the stock will always tell you more than management will. A RS would keep investors away like awesome says. I truly believe that’s completely off the table ...but I will let the stock show me. There's too much pending good news for MNKD right now. Whom ever controls the stock price (Not retailers) is going to wait until the very last minute before they start raising the price. You have Brazil Oct. PR, UTHR milestone payment, UTHR new molecule, Cohort 3 official PR and possible EPI Partner PR.....All can happen in the 2H19. The ones of those that are widely anticipated as likely are probably already baked into share price. The positives have already occurred in investors minds and the stock therefore likely doesn't get a big bump from the anticipated. Obviously, if some of the things that are expected do not happen, that could have negative impact on stock... e.g. if something goes wrong and we don't get the next UTHR milestone in the timeframe management has said it will occur. EPI is the only one of those that would be a surprise positive.
|
|
|
Post by alethea on Aug 14, 2019 12:48:56 GMT -5
There's too much pending good news for MNKD right now. Whom ever controls the stock price (Not retailers) is going to wait until the very last minute before they start raising the price. You have Brazil Oct. PR, UTHR milestone payment, UTHR new molecule, Cohort 3 official PR and possible EPI Partner PR.....All can happen in the 2H19. The ones of those that are widely anticipated as likely are probably already baked into share price. The positives have already occurred in investors minds and the stock therefore likely doesn't get a big bump from the anticipated. Obviously, if some of the things that are expected do not happen, that could have negative impact on stock... e.g. if something goes wrong and we don't get the next UTHR milestone in the timeframe management has said it will occur. EPI is the only one of those that would be a surprise positive. Isn't it odd that since the excellent conference call last week, that the stock price did not go up a single penny? And yesterday's event by Martine of UTHR foretells good or great things to come for MNKD and again, not a penny of price increase. In fact MNKD share price is down several % from before the conf call. As Nate says (I'm paraphrasing) this is singularly the most extreme, unbalanced, most lopsided thing I've seen in over 20 years in the market. In MY own words... criminally manipulated. This stock is and has been unethically, corruptly and illegally been manipulated for many years. It is artificially being held down in an extreme fashion. Why? Maybe some Big Pharma wants it suppressed until they themselves can get in the inhaled insulin game. The clock is ticking on patents. The UTHR collaboration alone is worth much more than current MNKD share price. And incidentally I finally bought a little UTHR after listening to Martine yesterday. A good anchor stock for portfolios.
|
|
|
Post by mytakeonit on Aug 14, 2019 13:05:11 GMT -5
There are two ways to look at everything ... get P'Oed about it ... or take advantage of the extra low pps and load up the truck. Shhhh don't tell anyone that I told you this.
But, that's mytakeonit
|
|
|
Post by ktim on Aug 14, 2019 13:24:00 GMT -5
The ones of those that are widely anticipated as likely are probably already baked into share price. The positives have already occurred in investors minds and the stock therefore likely doesn't get a big bump from the anticipated. Obviously, if some of the things that are expected do not happen, that could have negative impact on stock... e.g. if something goes wrong and we don't get the next UTHR milestone in the timeframe management has said it will occur. EPI is the only one of those that would be a surprise positive. Isn't it odd that since the excellent conference call last week, that the stock price did not go up a single penny? And yesterday's event by Martine of UTHR foretells good or great things to come for MNKD and again, not a penny of price increase. In fact MNKD share price is down several % from before the conf call. As Nate says (I'm paraphrasing) this is singularly the most extreme, unbalanced, most lopsided thing I've seen in over 20 years in the market. In MY own words... criminally manipulated. This stock is and has been unethically, corruptly and illegally been manipulated for many years. It is artificially being held down in an extreme fashion. Why? Maybe some Big Pharma wants it suppressed until they themselves can get in the inhaled insulin game. The clock is ticking on patents. The UTHR collaboration alone is worth much more than current MNKD share price. And incidentally I finally bought a little UTHR after listening to Martine yesterday. A good anchor stock for portfolios. The call was good, but other than financing nothing really new. The financing was good, but still came at a cost and has covenant milestones that are less than slam dunk likely... and the amount of new working capital doesn't make it obvious how cash flow breakeven is assured. Most other positive talking points were not new or radically different than expectations. So I'm not surprised that a rally hasn't occurred based on that. However, I too am surprised that UTHR's optimism about TreT hasn't had more of a positive impact. I guess I don't know enough about their market to understand what that is about. Does "the market" simply have low confidence in what UTHR claims regarding market? Is the discount for approval risk really that high (I would say quite low risk at this point)? or ?
|
|
|
Post by mytakeonit on Aug 14, 2019 13:57:53 GMT -5
Like I have said before, things will "start" to pick up in September. And yes, I do want to thank the "little" people who have made my quadruple going into fiveruple possible with very little cash.
But, that's mytakeonit
|
|
|
Post by ktim on Aug 14, 2019 16:26:26 GMT -5
Isn't it odd that since the excellent conference call last week, that the stock price did not go up a single penny? And yesterday's event by Martine of UTHR foretells good or great things to come for MNKD and again, not a penny of price increase. In fact MNKD share price is down several % from before the conf call. As Nate says (I'm paraphrasing) this is singularly the most extreme, unbalanced, most lopsided thing I've seen in over 20 years in the market. In MY own words... criminally manipulated. This stock is and has been unethically, corruptly and illegally been manipulated for many years. It is artificially being held down in an extreme fashion. Why? Maybe some Big Pharma wants it suppressed until they themselves can get in the inhaled insulin game. The clock is ticking on patents. The UTHR collaboration alone is worth much more than current MNKD share price. And incidentally I finally bought a little UTHR after listening to Martine yesterday. A good anchor stock for portfolios. The call was good, but other than financing nothing really new. The financing was good, but still came at a cost and has covenant milestones that are less than slam dunk likely... and the amount of new working capital doesn't make it obvious how cash flow breakeven is assured. Most other positive talking points were not new or radically different than expectations. So I'm not surprised that a rally hasn't occurred based on that. However, I too am surprised that UTHR's optimism about TreT hasn't had more of a positive impact. I guess I don't know enough about their market to understand what that is about. Does "the market" simply have low confidence in what UTHR claims regarding market? Is the discount for approval risk really that high (I would say quite low risk at this point)? or ? Actually, I'll correct myself for overlooking something. There also was the Amphastar restructure. That was positive surprise (to me anyway). So I guess overall I'd say the CC should have moved the share price in the positive direction. Perhaps it would have if the overall market were more in a risk-on environment vs risk-off. I bought some more (speculative) shares today, so I'm doing my part
|
|
|
Post by prcgorman2 on Aug 14, 2019 17:05:51 GMT -5
The call was good, but other than financing nothing really new. The financing was good, but still came at a cost and has covenant milestones that are less than slam dunk likely... and the amount of new working capital doesn't make it obvious how cash flow breakeven is assured. Most other positive talking points were not new or radically different than expectations. So I'm not surprised that a rally hasn't occurred based on that. However, I too am surprised that UTHR's optimism about TreT hasn't had more of a positive impact. I guess I don't know enough about their market to understand what that is about. Does "the market" simply have low confidence in what UTHR claims regarding market? Is the discount for approval risk really that high (I would say quite low risk at this point)? or ? Actually, I'll correct myself for overlooking something. There also was the Amphastar restructure. That was positive surprise (to me anyway). So I guess overall I'd say the CC should have moved the share price in the positive direction. Perhaps it would have if the overall market were more in a risk-on environment vs risk-off. I bought some more (speculative) shares today, so I'm doing my part I would say "great minds think alike", but I've blogged too much to make any claim on having a great mind. In any case, I also bought more shares today. Cheers!
|
|